Evommune Inc. (EVMN) vs EyePoint, Inc. (EYPT)

Evommune Inc. and EyePoint, Inc. are both Biotechnology companies. Evommune Inc. and EyePoint, Inc. are of similar size ($324.2M and $309.9M). Evommune Inc. has the higher net margin (0.00% vs −10,998.7%) and the lower return on invested capital (−82.5% vs 0.00%). Across the 13 metrics below, Evommune Inc. leads on 9 and EyePoint, Inc. on 4.

Valuation

Metric EVMN EYPT Biotechnology median
P/E n/m n/m 7.88
P/S n/m 112.37 11.47
P/B 1.10 1.88 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m 49.88 10.73
Earnings yield (130.22%) (103.31%) (28.84%)
Free cash flow yield (24.39%) (86.54%) (23.03%)

Profitability

Metric EVMN EYPT Biotechnology median
Gross margin — 41.75% 65.16%
Operating margin 0.00% (11,369.30%) 0.00%
Net margin 0.00% (10,998.67%) 0.00%
Free cash flow margin 0.00% (9,724.68%) 0.00%
Return on equity (141.99%) (148.70%) (57.72%)
Return on assets (62.71%) (115.86%) (49.22%)
Return on invested capital (82.46%) 0.00% 0.00%

Growth

Metric EVMN EYPT Biotechnology median
Revenue growth (TTM) — (94.63%) 5.64%
EPS growth (last fiscal year) 75.23% (36.64%) —
Revenue growth, 5-year CAGR — (1.85%) 8.40%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric EVMN EYPT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 11.68 4.50 4.73
Net debt to EBITDA 1.87 1.24 0.96

Dividend

Metric EVMN EYPT Biotechnology median
Dividend yield — 1.26% 2.10%
Payout ratio — 0.00 0.00

Size

Metric EVMN EYPT Biotechnology median
Market cap 309.93m 324.15m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack